From Market Research to Strategic Intelligence: The Evolution of Roots Analysis
The information requirements of pharmaceutical and biotechnology companies have changed as the life-sciences landscape has become more interconnected. A commercial team assessing a new therapy area may need market data, clinical intelligence, competitor analysis, regulatory information and partnership activity at the same time. For organizations providing intelligence, this has reduced the practical separation between market research, competitive intelligence and consulting.
Roots Analysis (https://www.rootsanalysis.com/ ) illustrates this convergence through an organizational model that combines market research with competitive intelligence, consulting and technology-enabled intelligence platforms. Its current portfolio includes LabKairos and BioSignalIQ, which extend the organization's research capabilities into AI-enabled research access and commercial intelligence for life sciences.
LabKairos Changes How Research Is Accessed
Technology introduces another dimension to this evolution. LabKairos (https://www.rootsanalysis.com/labkairos )is described by Roots Analysis as an AI market-intelligence platform powered by the organization's proprietary research library covering pharma, biotech and healthcare. The platform is designed to provide sourced answers, with claims resolving to specific reports, editions and pages.
The significance is not simply that an AI interface exists. It changes the way accumulated research can be accessed. Analysts, investors and strategy teams can approach a research library through questions rather than manually searching across individual documents.
Roots Analysis also states that LabKairos combines AI access with human intelligence, with analysts available for custom research, forecasts and deeper analysis.
BioSignalIQ Extends Intelligence Toward Commercial Prioritization
BioSignalIQ represents a different application of technology-enabled intelligence. Roots Analysis describes the platform as tracking company and market developments, assessing their commercial relevance and helping teams prioritize accounts according to timing and fit.
Its workflow connects market developments to verified signals, account context, priority and timing, followed by potential action and historical context. The platform monitors clinical, regulatory, manufacturing, partnership and investment activity.
This creates a distinction between research accessibility and commercial intelligence. LabKairos focuses on making a research knowledge base accessible through AI, while BioSignalIQ is designed around identifying and prioritizing commercially relevant life-sciences signals.
